Julien Robert-Paganin

7PUBLICATIONS
20CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Regenerative medicine (incl. stem cells)Molecular medicineMedical parasitologyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 04, 2026
Dynamics of the β-cardiac myosin auto-inhibited state explain cardiomyopathy pathogenesis.

|Aug 28, 2024
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy.

James J Hartman, Darren T Hwee, Julien Robert-Paganin

|Aug 27, 2024
Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy.

James A Spudich, Neha Nandwani, Julien Robert-Paganin

|Jun 07, 2024
Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction.

Daniel Auguin, Julien Robert-Paganin, Stéphane Réty

|Jun 12, 2023
Mechanism of small molecule inhibition of Plasmodium falciparum myosin A informs antimalarial drug design.

Dihia Moussaoui, James P Robblee, Julien Robert-Paganin

|May 31, 2023
Cryo-EM structure of the folded-back state of human β-cardiac myosin.

Alessandro Grinzato, Daniel Auguin, Carlos Kikuti

Pageof 2

Frequent Collaborators

7 joint publications

Anne Houdusse

4 joint publications

Daniel Auguin

3 joint publications

Carlos Kikuti

3 joint publications

Neha Nandwani